Insulin Delivery: What Are the Options?

Please read the following information and select the appropriate link at the bottom of the page to continue.

Target Audience: Pharmacists, nurses, and dietitians who are involved with patient education and counseling

Goal: To address the important role of insulin delivery systems in helping patients meet their individual therapeutic goals

Educational Objectives: Upon completion of this activity participants should be able to:

• State two requirements for intensive therapy
• Describe three options for insulin delivery
• Discuss advantages and disadvantages of insulin pen use
• Identify two insulin delivery systems in research or development
  

	Pharmacists: The American Association of Diabetes Educators and Novo Nordisk Pharmaceuticals, Inc. are accredited by the American Council on Pharmaceutical Education (ACPE) as providers of continuing pharmaceutical education. This program provides for 1.0 contact hours (0.1 CEUs) of continuing education credit. ACPE Universal Program Number 069-360-03-023-H04.
	Registered Nurses: This continuing nursing education activity has been approved for 1.2 contact hours by the American Association of Diabetes Educators, an accredited approver of continuing nursing education by the American Nurses Credentialing Center's Commission of Accreditation. Approval number 0203-020.
	Dietitians: American Association of Diabetes Educators (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from June 1, 2003 to May 31, 2006. Registered dietitians (RD) and dietetic technicians, registered (DTR) will receive 1.0 Continuing Professional Education Unit (CPEU) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Initial Release Date: 03/27/03
Planned Expiration Date: 03/27/05

To receive a statement of credit, you must:

• Successfully complete the post-test (70% or better).
• Complete the program evaluation.

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form. The statement of credit specific to your discipline will appear on your screen and you will be given the option to print it for your files. No additional statement of credit will be issued.

Activity Presenter:

Virginia Peragallo-Dittko, RN, BC-ADM, MA, CDE
Director of the Diabetes Education Center
Winthrop-University Hospital
Mineola, New York

The following program is a presentation by Virginia Peragallo-Dittko. Ms. Peragallo-Dittko is the Director of the Diabetes Education Center at Winthrop-University Hospital in Mineola, New York. She has been a diabetes nurse-specialist in a variety of settings since 1979. She was named Diabetes Educator of the Year by the American Association of Diabetes Educators and has been a member of the Editorial Board of The Diabetes Educator journal. Ms. Peragallo-Dittko is the editor of the textbook, A Core Curriculum for Diabetes Education, second edition and Addendum. She serves as Editor-in-Chief of Program Publications for the American Diabetes Association. She has published in the area of diabetes education in books as well as lay and professional journals. She has lectured extensively for both lay and professional audiences and has participated in both radio and television interviews.

Fee: There is no fee to receive credits for this program.

Commercial Supporter: This program has been supported through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

Trademarks:

Animas R 1000 is a registered trademark of Animas Corporation.
Autopen is a registered trademark of Owen Mumford Company.
BD, Latitude, and BD Logic are trademarks of Becton Dickinson and Co.
Disetronic Pen, H-TRON plus are registered trademarks of Disetronic Medical Systems.
Medi-Jector Choice is a trademark of Antares Pharma, Inc.
MiniMed Paradigm is a registered trademark of Medtronic MiniMed, Inc.
Humulin, Humalog, and Humalog Mix75/25™ are registered trademarks of Eli Lilly and Company.
NovoPen, Velosulin, Novolin, Innovo, InnoLet, FlexPen, NovoLog, and PenFill are registered trademarks of Novo Nordisk A/S.
Novolin Prefilled is a trademark of Novo Nordisk A/S.
IN TOUCH, OneTouch Ultra, and InDuo are registered trademarks of Lifescan, Inc.

Disclosure Declaration: It is the policy of Novo Nordisk Pharmaceuticals, Inc. and the American Association of Diabetes Educators to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in the activity or with the supporter of this continuing education activity. The information is for participant information; it is not assumed that these relationships will have a negative impact on the content of the activity.

Ms. Peragallo-Dittko has disclosed that she has received an honorarium for narrating this activity.

Disclaimers:

• Approval of credit for this continuing education program does not imply endorsement by AADE of any product or manufacturer identified.
• Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
• This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA).
• Novo Nordisk Pharmaceuticals, Inc., the American Association of Diabetes Educators, and the activity's faculty do not endorse the use of any product in a manner that is not approved by the FDA.

  The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Click the appropriate profession to continue to the activity:

Pharmacists click here

Nurses click here

Dietitians click here

Other Healthcare Professionals click here

Copyright © 2003 Novo Nordisk Pharmaceuticals, Inc. All rights reserved. 125891

For our Terms of Use and Privacy Policy, please review our Legal Agreement.
Copyright© 2004 CECity® All rights reserved.